RD
Rati Desai
About Rati Desai
Data last updated:
Rati Desai is a Director at Shiva Pharmachem Limited (since 2023), Director at Alembic Limited (since 2019) and Director at Alembic City Limited (since 2024), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Pharma and Real Estate and Construction. The 4 current companies with reported revenue have a combined latest revenue of ₹1,263 Cr; the largest is Shiva Pharmachem Limited at ₹873 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shiva Pharmachem Limited U24231GJ1999PLC035615 | Director | 01 Mar 2023 | 1999 | ₹873 Cr (FY 2025) | Active |
 Alembic Limited L26100GJ1907PLC000033 | Director | 13 Aug 2019 | 1907 | ₹313 Cr (FY 2026) | Active |
 Alembic City Limited U70100GJ1994PLC021552 | Director | 07 Aug 2024 | 1994 | ₹38.41 Cr (FY 2025) | Active |
 Alembic City Limited U68100GJ1994PLC021552 | Director | 07 Aug 2024 | 1994 | ₹38.41 Cr (FY 2025) | Active |
Board colleagues of Rati Desai
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rati Desai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rati Desai
Rati Desai currently holds 4 directorships: Shiva Pharmachem Limited (Director, since 01 Mar 2023, revenue ₹873 Cr (FY 2025)); Alembic Limited (Director, since 13 Aug 2019, revenue ₹313 Cr (FY 2026)); Alembic City Limited (Director, since 07 Aug 2024, revenue ₹38.41 Cr (FY 2025)); Alembic City Limited (Director, since 07 Aug 2024, revenue ₹38.41 Cr (FY 2025)).
Rati Desai was first appointed on 13 Aug 2019 as Director at Alembic Limited. The most recent appointment on record is 07 Aug 2024 at Alembic City Limited.
The 4 current companies of Rati Desai that report revenue have a combined latest revenue of ₹1,263 Cr: Shiva Pharmachem Limited ₹873 Cr (FY 2025); Alembic Limited ₹313 Cr (FY 2026); Alembic City Limited ₹38.41 Cr (FY 2025); Alembic City Limited ₹38.41 Cr (FY 2025).
The current boards of Rati Desai's companies include Dukhabandhu Rath (Shiva Pharmachem Limited), Himali Harnish Patel (Shiva Pharmachem Limited), Madhavi Vishal Agrawal (Shiva Pharmachem Limited), Milin Kaimas Mehta (Shiva Pharmachem Limited), Rahul Rakesh Agrawal (Shiva Pharmachem Limited), Rakesh Shiwebhagwan Agrawal (Shiva Pharmachem Limited), among others.